1 / 13

DVT PROPHYLAXIS

DVT PROPHYLAXIS. SUNDIP PATEL 7 / 15 / 2009. BACKGROUND. D eep V ein T hrombosis is a common, yet preventable peri-operative complication Highest risk in critical care and spinal cord injury patients – 60-80% Post–General Surgery procedures: 15-40% Post-Ortho Procedures: 40-60%

ryder-lindsay
Download Presentation

DVT PROPHYLAXIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. DVT PROPHYLAXIS SUNDIP PATEL 7 / 15 / 2009

  2. BACKGROUND • Deep Vein Thrombosis is a common, yet preventable peri-operative complication • Highest risk in critical care and spinal cord injury patients – 60-80% • Post–General Surgery procedures: 15-40% • Post-Ortho Procedures: 40-60% • Variable for Urologic cases

  3. BACKGROUND • Pulmonary Embolus • True Prevalance is unknown • W/O prophylaxis • Fatal PE in 0.2-.9% of ELECTIVE general surgery cases • Fatal PE in 0.1-2.0% of ELECTIVE hip • Fatal PE in 2.5-7.5% of Fractured Hip

  4. VIRCHOW TRIAD • STASIS • From supine positioning and effects of anesthesia • HYPERCOAGULABILITY • Decreased clearance of the PROcoagulant • INTIMAL INJURY • Results from excessive vasodilation caused by vasoactive amines and anesthesia • Acting in concert, these 3 factors promote development of DVT in low-flow areas

  5. RISK FACTORS • AGE > 50 • Hx of varicose veins • Hx of MI • Hx of Cancer • Hx of AFib • Hx of ISCHEMIC Stroke • Hx of DM

  6. Urologic Risk • RISK Level for most UROLOGIC patients are considered MODERATE

  7. UROLOGIC RISK • Risk of DVT w/o prophylaxis is 10 – 40% • RECS: • Low Molecular Weight Heparin (Lovenox) • Low Dose Unfractionated Heparin • Fondaparinux (ARIXTRA) • Also appropriate to use is • Graduated Compression Stockings • Intermittent Pneumatic Compression • Venous Foot Pumps

  8. Types of MEDICAL prophylaxis • ARIXTRA • Longer half-life than LMWH (17H v 4H) • Not for CKD pts • No monitoring • Single daily dosing • LMWH (lovenox) • Greater bioavailability • Longer duration • Little monitoring needed • HIT incidence less • LDUH • Easy administration • Cost Effective • Little monitoring needed

  9. UROLOGIC PROCEDURES • Transurethral – EARLY AMBULATION • IF HIGHER RISK, GCS OR IPC • Anti-incontinence and pelvic reconstructive surgery • Low risk – early ambulation • Mod risk – IPC or LMWH • Hi Risk – IPC + LDUH or LMWH • Urologic laparoscopic and/or robotically assisted - IPC • Open Procedures - IPC

  10. CONTRAINDICATIONS • ABSOLUTE • Active bleeding, PLT:20, neurosurgery, ocular surgery, intracranial bleeding w/in 10 days • RELATIVE • PLT:20-100, brain metastases, major abdominal surgery w/in past 2 days, GI bleeding or GU bleeding w/in past 14 days, infective endocarditis, malignant hypertension

  11. PROPHYLAXIS OPTIONS • LMWH – 40mg SQ qd • LDUH – 5000u SQ B-TID • ARIXTRA – 2.5 SQ qd NOT for patients with CrCl <30 For LOW RISK procedures and those with NO RISK FACTORS, no prophylaxis is required. ENCOURAGE AMBULATION EARLY AND FREQUENTLY

  12. UROLOGIC RECOMENDATIONS • MAJOR, OPEN PROCEDURES • EITHER LMWH, LDUH, ARIXTRA (GRADE1A) • IF HIGH RISK OF BLEEDING, USE MECHANICAL METHODS UNTIL • LAPAROSCOPIC • IF previous dvt/pe, LMWH or LDUH, may also add IPC or GCS (Grade 1C) ALL PATIENTS WITH HISTORY OF CANCER

  13. SUMMARY • ALL PATIENTS UNDERGOING ANY SURGERY SHOULD HAVE DVT PROPHYLAXIS • GCS AND EARLY AMBULATION SUFFICIENT IN MOST CASES • CONTINUE PROPHYLAXIS UNTIL AMBULATING

More Related